Artelo Biosciences : Annual Transition Report (Form 10-KT) :

artl_10kt.htm














UNITED STATES


SECURITIES AND EXCHANGE COMMISSION
... | March 21, 2022

Related Keywords

Japan , Nevada , United States , United Kingdom , Washington , Solana Beach , California , China , San Diego County , Ireland , Dublin , Canada , Spain , America , Canadian , Japanese , Lomas Santa Fe , Trinity College Dublin , Good Laboratory Practice , Research Development , Astrazeneca , Pfizer Inc , Clinical Health , Tetra Bio Pharma Inc , Department Of Justice , Stony Brook University Relationship , National Institutes Of Health , University Of Western Ontario , Drug Administration , Children Health Insurance Program , Trinity Reliant Ventures , Artelo Biosciences Inc , Biopharmaceuticals Inc , Nasdaq Stock Market , Securities Exchange , International Laws , Helsinn Therapeutics Us Inc , Jazz Pharmaceuticals Inc , Development Phase , Us Health Insurance Portability , Foundation The Patent Rights , Nasdaqstock Market , European Union , Novartis International , Administration Of Oral Single Ascending Doses , Health Information Technology For Economic , Growth Company , Artelo Biosciences , Stony Brook University , European Medicines Agency , Artelo Biosciences Corporation , Mark One , Zip Code , Pact Yes , Securities Exchange Act , Interactive Data File , Regulations T , Sarbanes Oxley Act , Exchange Act , Common Stock , Transition Report , Financial Condition , United States Dollars , Trinity Reliant Ventures Limited , Artelo Biosciences Limited , Cancer Appetite Recovery Study , Fatty Acid Binding Protein , National Institutes , Post Traumatic Stress Disorder , Western Ontario , Inflammatory Bowel Disease , Candidate Pipeline , Cannabinoid Agonist , Bowel Disease , Transition Reports , Annual Reports , Quarterly Reports , Current Reports , First Amendment , Data Transfer , License Agreement , Single Ascending Dose , Multiple Ascending Dose , First Time , Placebo Controlled Study , Investigate Safety , Oral Single Ascending Doses , Healthy Volunteers , Japanese Healthy Male Volunteers , Placebo Controlled Crossover Study , Evaluate Effects , Single Oral Dose , Topical Capsaicin Evoked Pain , Double Blind , Analgesic Efficacy , Single Dose , Interaction Study , After Administration , Oral Multiple Ascending Doses , Adult Subjects , Chronic Low Back , Research Foundation , Stony Brook Agreement , Patent Product , Annual Minimum Royalty , Annual Minimum , Licensed Subject Matter , First Commercial Sale , Net Sales , Helsinn Therapeutics , Tetra Bio Pharma , Federal Food , Cosmetic Act , Laboratory Practice , Investigational New Drug , Good Manufacturing Practice , Risk Evaluation , Mitigation Strategy , Foreign Corrupt Practices Act , Anti Kickback Statute , False Claims Act , Insurance Portability , Accountability Act , Health Information Technology , Clinical Health Act , Payments Sunshine Act , Health Insurance Program , Nc Stock Exchange , News , Information , Press Release , United , Securities , End , Xchange Artl Us04301g2012 ,